ArticleActa ophthalmologica2022

12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry.

Mateusz Niedzwiecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.